Peer Review History

Original SubmissionSeptember 20, 2019
Decision Letter - Manuel Garza León, Editor

PONE-D-19-26513

The relationship between environmental sources and the susceptibility of Acanthamoeba keratitis in the United Kingdom

PLOS ONE

Dear Dr Carnt,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Feb 14 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Manuel Garza León

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Financial Disclosure section:

'British Contact Lens Association, Dallos award, 2015 (Carnt and Kilvington). Dr

Carnt was supported by an NHMRC Early Career CJ Martin Fellowship (APP1036728).  The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health'

We note that one or more of the authors are employed by a commercial company: 

Research Organisation (KC) Ltd, and Ophtecs Corporation.

a. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

b. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

c. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Line 138-139 – Spouts have the fastest flowing and largest volume of water flowing through it with thousands of gallons per month, this may be the reason why you do not see as much bacteria/Acanthamoeba/FLA in that particular area for Fig 3. Should repeat samples be taken from the drain or overflows from these areas for future studies? Please comment/discuss this finding.

Do you think that paranoia of patients when sampling they didn’t want to see Acanthamoeba or FLA within their home that they may have stringently cleaned between sampling?

All figures/graphs are of poor quality please use another software program.

Were attempts to characterize the species/isolate causing the AK in these 4 patients?

Supplemental information is clear for samplers.

Molecular characterization of FLA should become mandatory in future studies.

Reviewer #2: Overall, it is a very well written case-control study on the association between environmental sources of contamination and Acanthamoeba keratitis in UK.

As recommended, please include the statistical analysis used for this study in the manuscript (as it is included only in the abstract). As a suggestion, including the odds ratio of exposure to tap water in the AK patient vs the corresponding ratio for control group, would be really interesting.

Great job!

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Christopher Aaron Rice

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: The relationship between environmental sources and the susceptibility of Acanthamoeba keratitis in the United Kingdom.Carnt.2019.docx
Revision 1

Major changes

• As your study was designed to search for Acanthamoeba and then record the presence of other FLA I would switch this throughout the text. “To determine whether Acanthamoeba keratitis (AK) patients have higher rates of Acanthamoeba or other free-living amoeba (FLA) colonising domestic sinks than control contact lens (CL) wearers, and whether these isolates are genetically similar to the corneal isolates identified from their CL associated AK.”

Answer: The sentence has been modified as suggested.

• There is no description of the other FLA identified, can you describe which others were investigated and found?

o Can this also be broken down within the bar graphs?

Answer: Classification of FLA were not attempted in this study and this was mentioned as a limitation of the study.

“A limitation of this study is that the genus-level identification of FLA by molecular methods was not performed. FLA such as Hartmannella and Vahlkampfiid amoebae [4, 5], although rare compared to Acanthamoeba, are also causative agents of keratitis. In addition, the significantly higher FLA positive samples in the patient cohort suggests that their identification in the genus-level will help to better understand the risk of keratitis associated with domestic tap water. Further studies regarding the pathogenicity of FLA and Acanthamoeba will also require assessing the source of transmission as well as the severity of AK”

• The quality of all of the figures need to be improved (use graph pad prism or another software for better images).

Answer: Figures have been reformatted as suggested

Figure 1.

• Do these graphs describe the full picture? Although the graphs tell the reader total numbers it doesn’t break down the exact number of samples obtained from the spout from the kitchen of an AK wearer or the drain from the bathroom of a CL control as examples. A reorganization and coloration to be more descriptive may be useful.

Answer: Figures have been reformatted to keep numbers of samples.

Figure 2.

• As you are specifically identifying different FLA, this graph could be a stacked bar graph with different colors representing the different genus of FLA found for both groups and areas swabbed.

Answer: Figures have been reformatted as suggested

As mentioned above genus level identification for FLA was not attempted.

Minor Changes

• Lines 19-21, 37-41, 79, 113 – switch Acanthamoeba and FLA order.

Answer: The order has been corrected as suggested throughout the manuscript.

• Don’t you think using E. coli and 32°C selects for Acanthamoeba over other FLA?

Answer: FLA could be thermophilic (Hartmannella vermiformis and Naegleria) as indicated in this paper https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469187/. Data of the current study showed that rate of isolation of FLA was higher than that of Acanthamoeba. Therefore, we believed that the incubation condition does not select one over the other.

• There was no discussion to where the patients were from within the UK (distribution, were these all local to a particular area? – This data should be easily accessible since collected during the questionnaire). Can you make a conclusion about geographic location, potential differences in water storage methods, sources that the water was from or treatment methods? You may find that there was a particular area that could have an increased risk or contamination. This could be useful for water regulatory and treatment of such bodies of water.

Answer: Yes, we agree that this information would be useful in many ways. However, we were able to collect this information from less than 1/4 of case and controls. Therefore, this analysis has not been added in the manuscript.

• Why were only 4 patients out of 129 compared for Ac coxA? Please discuss.

Answer: Due to time frame of the project, resources and funding availability, we have selected samples from only four patients for genetic characterization. These four patients appeared to have striking association with detection of Acanthamoeba in water sample from their homes. Our aim was to show relatedness between pathogenic and environmental isolates. We have clarified this in manuscript as

Four AK patients were selected to the study genetic relatedness between pathogenic and environmental isolates on the basis of association between case and detection of Acanthamoeba in water samples from their homes. Partial sequence of the mitochondrial cytochrome oxidase gene (coxA 1/2) was obtained from Acanthamoeba isolates of four different keratitis patients and those sequences were compared with isolates from the patient’s home.

Lines 24-26 – “The samples were cultured by inoculating onto a non-nutrient agar plate seeded with Escherichia coli and the plates were incubated at 32˚C and examined for amoebae by microscopy for up to 2 weeks.” Could read as “The samples were cultured by inoculating onto a non-nutrient agar plate seeded with Escherichia coli, incubated at 32˚C and examined for amoebae by microscopy for up to 2 weeks.”

Answer: The sentence has been corrected as suggested

• Lines 30-36 – Please add the %’s for spouts, drains, overflow in kitchens and bathrooms.

Answer: Percentage for sampling sites have been added

“Spouts (kitchen 6.7%, bathroom 11%) had the lowest rate of Acanthamoeba isolation compared to drains (kitchen 18.2%, bathroom 27.9%) and overflow (kitchen 39.1%, bathroom 25.9%) either in kitchens or bathrooms (p<0.05). There was no statistically significant difference between the prevalence of Acanthamoeba in all three sample sites in kitchens (16.9%) compared to all three sample sites in bathrooms (21.5%) and no association for Acanthamoeba prevalence between AK patients and CL controls.”

• Line 36 – Was this the kitchen or bathroom sink?

Answer: It was from both the kitchen and the bathroom. The sentence has been modified as

“All four corneal isolates had the same coxA sequence as at least one domestic water isolate from the patients’ sink of the kitchen and the bathroom.”

• Line 46 – Change “potentially” to opportunistically. Where these the different types of FLA identified within this study? Please make reference to which ones?

Answer: This has been changed as suggested.

• Line 71 – Reference to ref 11 not needed here since it is referenced at the end of the sentence.

Answer: The reference has been deleted.

• Line 95-96 – If 23x repeat samples were taken from 129 patients from 6 locations within the home there would be 17,802 samples? I would remove this sentence. Or please show the succession of each patient over the 23 month period as a supplemental figure.

Answer: The sentence has been rewritten to avoid this confusion.

“A total of 23 repeat samples at least one month apart were collected from patient’s kitchen and bathroom”

• Line 114 – 513 total samples were obtained from AK patients = 6.6 samples per patient? 189 samples from 40 CL controls = 4.7 samples per patient?

Answer: As mentioned in methods, each patient was provided with six sample collecting pack. However, some of them had not returned all six tubes with sample plus we collected 23 repeat samples from AK patents. This is the reason; the sample numbers are not exact multiple of patient number. To avoid any confusion, the sentence has been modified as

“A total of 513 samples from 77 AK patients and 189 samples from 40 CL controls were retrieved and examined in this study.”

Furthermore, the distribution of sample in figure 1 shows that proportion of samples collected from different sites are different.

Figure 1.

• Please add in total numbers for each of the described %’s within the pie chart.

Answer: This has been updated in figure 1.

• Please add discussion about why the 1.17% (6 cases) from the Cloakroom of AK patients was removed.

Answer: This has been added as

“Samples collected from the cloakrooms of AK patients were excluded from the current analysis because the number of samples were small (1.7%) and there were no cloakrooms samples from CL controls group.”

• Line 121 – (The Acanthamoeba comparison should be Figure 2 not “Fig 1”. Also spell out figure to keep consistent throughout the MS.

Answer: Corrections made as suggested.

• Line 123-124 – Do both groups (AK patients and CL control) FLA total include the Acanthamoeba data as well? If so, shouldn’t this be removed/normalized?

Answer: In the current analysis, FLA group includes Acanthamoeba or FLA. The rate of presence of Acanthamoeba and FLA was analysed separately for each sampled area. Therefore, there were no duplicate isolates in the analysis. To clarify this, following modifications have been added

“Samples identified with Acanthamoeba were classified as Acanthamoeba positive and those with Acanthamoeba or FLA were classified as FLA in the current analysis.”

Figure 2.

• Please shorten the significance bar for the ** between the FLA found in patients and controls.

Answer: Figure has been reformatted as suggested

• Please keep consistency between titles of groups for all figures, “AK patients” and “CL controls”.

Answer: Corrections have been made throughout

• Line 131-137 – Please include the * for level of significance.

Answer: Correction has been made

• Line 133-137 – Please spell out figure to keep consistency throughout the MS.

Answer: Corrections have been made throughout

• Line 142 – Please Italicize Acanthamoeba.

Answer: Corrections have been made throughout

Figure 3&4.

• Please keep consistency between titles of groups for all figures, “AK patients” and “CL controls”.

Answer: Corrections have been made throughout

• Please shorten the significance bar and center the * for kitchen drain and bathroom overflow.

Answer: Figure has been reformatted as suggested

Table 1.

• Please centers align and middle aligns text into the center of all boxes of the table.

Answer: Table has been formatted as suggested.

• References font changes.

Answer: Font has been changed to match with manuscript’s font.

Reviewer # 1

Line 138-139 – Spouts have the fastest flowing and largest volume of water flowing through it with thousands of gallons per month, this may be the reason why you do not see as much bacteria/Acanthamoeba/FLA in that particular area for Fig 3. Should repeat samples be taken from the drain or overflows from these areas for future studies? Please comment/discuss this finding.

Answer: Discussion has been added (line 191 -194)

In the current study tap spouts tended to have filters on them making it difficult to swab the inside of spouts and this could be the reason for these differences [11]. In addition, spouts have the fastest water flow and large volume of water regularly flows through it, which self-flushes the spouts and may prevent colonisation of FLA.

Do you think that paranoia of patients when sampling they didn’t want to see Acanthamoeba or FLA within their home that they may have stringently cleaned between sampling?

Answer: While a small number of the first samples changed from positive to negative, a similar amount changed in the other direction in repeat sampling. Therefore, it does not appear that this had an effect.

All figures/graphs are of poor quality please use another software program.

Answer: figures have been modified for better quality.

Were attempts to characterize the species/isolate causing the AK in these 4 patients?

Answer: No, only the coxA gene was sequenced.

Supplemental information is clear for samplers.

Answer: Participants were given a verbal instruction and provided with written instruction.

Molecular characterization of FLA should become mandatory in future studies.

Answer: Yes, Authors agree with this and discus it in the manuscript.

Reviewer #2:

Overall, it is a very well written case-control study on the association between environmental sources of contamination and Acanthamoeba keratitis in UK.

Answer: Authors like to thank reviewer for taking time to review the manuscript and providing comment on it.

As recommended, please include the statistical analysis used for this study in the manuscript (as it is included only in the abstract). As a suggestion, including the odds ratio of exposure to tap water in the AK patient vs the corresponding ratio for control group, would be really interesting.

Answer: Thank you for suggesting this. Statistical analysis has been added to in the methods of the manuscript as suggested. Odd ratios have been included in results.

“Statistical analysis

The Pearson Chi-square test was used to assess whether there was a statistically significant difference in the association between sampling sites. Odds ratios and their 95% confidence intervals (95% CIs) were calculated to measure association between AK cases and detection rate of Acanthamoeba and FLA in AK patients’ and CL controls’ homes.”

Great job!

Decision Letter - Manuel Garza León, Editor

The relationship between environmental sources and the susceptibility of Acanthamoeba keratitis in the United Kingdom

PONE-D-19-26513R1

Dear Dr. Carnt,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Manuel Garza León

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Manuel Garza León, Editor

PONE-D-19-26513R1

The relationship between environmental sources and the susceptibility of Acanthamoeba keratitis in the United Kingdom

Dear Dr. Carnt:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Manuel Garza León

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .